CYTOSAR Trademark

Trademark Overview


On Friday, September 22, 1967, a trademark application was filed for CYTOSAR with the United States Patent and Trademark Office. The USPTO has given the CYTOSAR trademark a serial number of 72280989. The federal status of this trademark filing is EXPIRED as of Saturday, May 16, 2009. This trademark is owned by UPJOHN COMPANY, THE. The CYTOSAR trademark is filed in the Pharmaceutical Products category with the following description:

ANTITUMOR AGENT

General Information


Serial Number72280989
Word MarkCYTOSAR
Filing DateFriday, September 22, 1967
Status900 - EXPIRED
Status DateSaturday, May 16, 2009
Registration Number0858206
Registration DateTuesday, October 8, 1968
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesANTITUMOR AGENT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code9 - Expired
Class Status DateSaturday, May 16, 2009
Primary Code018
First Use Anywhere DateTuesday, February 21, 1967
First Use In Commerce DateTuesday, February 21, 1967

Trademark Owner History


Party NameSICOR, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressIRVINE, CA 926181902

Party NameUPJOHN COMPANY, THE
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKALAMAZOO, MI 49001

Trademark Events


Event DateEvent Description
Saturday, May 16, 2009CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, November 12, 2008CASE FILE IN TICRS
Saturday, October 8, 1988REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)
Wednesday, October 5, 1988REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8

Related Keywords


cytosar agent antitumor